A cell model system to study regulation of phosphotidylinositol 3-kinase and protein kinase B activity by cytokines/growth factors produced by type I collagen stimulated immune cells from patients with systemic sclerosis

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 8, 2007, Pages 1181-1186

  Chiang, Thomas M ^a,b   Postlethwaite, Arnold E ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

collagen; nitric oxide synthase; nitrotyrosylation of protein; platelet; protein kinase B; Systemic sclerosis

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; CYTOKINE; GROWTH FACTOR; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ARTICLE; BLOOD VESSEL WALL; CELL CULTURE; CELL ISOLATION; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; OSTEOARTHRITIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RHEUMATOID ARTHRITIS; SUPERNATANT; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THROMBOCYTE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CELL LINE; CELLS, CULTURED; COLLAGEN TYPE I; CULTURE MEDIA; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEGAKARYOCYTES; NITRIC OXIDE SYNTHASE; OSTEOARTHRITIS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; SCLERODERMA, SYSTEMIC; TYROSINE;

EID: 34347227433     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2007.04.003     Document Type: Article

References (31)

1. Kahaleh M.B., Scharstein K.K., and LeRoy E.C. Enhanced platelet adhesion to collagen in scleroderma. Effect of scleroderma plasma and scleroderma platelets. J. Rheumatol. 12 (1985) 468-471
2. Chiang T.M., Takayama H., and Postlethwaite A.E. Increase in platelet non-integrin type I collagen receptor in patients with systemic sclerosis. Thromb. Res. 117 (2006) 299-306
3. Chiang T.M., and Postlethwaite A.E. Increase in phosphoatidylinositide-3-kinase activity by nitrotyrosylation of lysates of platelets from patients with systemic sclerosis. Biochim. Biophys. Acta 1760 (2006) 32-37
4. Stojanovic A., Marjanovic J.A., Brovkovych V.M., Peng X., Hay N., Skidgel R.A., and Du X. A phosphoinositide 3-kinase-Akt-nitric oxide-cGMP signaling pathway in stimulating platelet secretion and aggregation. J. Biol. Chem. 281 (2006) 16333-16339
5. Janmey P.A., and Stossel T.P. Gelsolin-polyphosphoinositide interaction. Full expression of gelsolin-inhibiting function by polyphosphoinositides in vesicular form and inactivation by dilution, aggregation, or masking of the inositol head group. J. Biol. Chem. 264 (1989) 4825-4831
6. Hartwig J.H., Kung S., Kovasovics T., Janmey P.A., Cantley L.C., Stossel T.P., and Toker A. D3 phosphoinositides and outside-in integrin signaling by glycoprotein IIb-IIIa mediate platelet actin assembly and filopodial extension induced by phorbol 12-myristate 13-acetate. J. Biol. Chem. 271 (1996) 32986-32993
7. Rosado J.A., and Sage S.O. Phosphoinositides are required for store-mediated calcium entry in human platelets. J. Biol. Chem. 275 (2000) 9110-9113
8. Way B.A., and Mooney R.A. Activation of phosphatidylinositol-3-kinase by platelet-derived growth factor and insulin-like growth factor-1 is inhibited by a transmembrane phosphotyrosine phosphatase. J. Biol. Chem. 268 (1993) 26409-26415
9. Jackson S.P., Schoenwaelder S.M., Goncalves I., Nesbitt W.S., Yip C.L., Wright C.E., Kenche V., Anderson K.E., Dopheide S.M., Yuan Y., Sturgeon S.A., Prabaharan H., Thompson P.E., Smith G.D., Shepard P.R., Daniele N., Kulkarni S., Abbott B., Saylik D., Jones C., Lu L., Giuliano S., Hughan S.C., Anhus J.A., Robertson A.D., and Salem H.H. PI 3-Kinase p110 beta: a new target for antithrombotic therapy. Nat. Med. 11 (2005) 507-514
10. Cosemans J.M., Munnix I.C., Wetzker R., Heller R., Jackson S.P., and Heemskerk J.W.M. Continuous signaling via PI3K isoforms and is required for platelet ADP receptor function in dynamic thrombus stabilization. Blood 108 (2006) 3045-3052
11. Postlethwaite A.E. Connective tissue metabolism including cytokines in scleroderma. Curr. Opin. Rheumatol. 5 (1993) 766-772
12. Stuart J.M., Postlethwaite A.E., and Kang A.H. Evidence for cell-mediated immunity to collagen in progressive systemic sclerosis. J. Lab. Clin. Med. 88 (1976) 601-607
13. McKown K.M., Carbone L.D., Bustillo J., Seyer J.M., Kang A.H., and Postlethwaite A.E. Induction of immune tolerance to human type I collagen. Arthritis Rheum. 43 (2000) 1054-1061
14. Curram M., Pahwa S., and Frieri M. Augmented interleukin-6 secretion in collagen-stimulated peripheral blood mononuclear cells from patients with systemic sclerosis. Ann. Allergy 73 (1994) 493-496
15. Hawrylko E., Spertus A., Mele C.A., Oster N., and Frieri M. Increases interleukin-2 production in response to human type I collagen stimulation in patients with systemic sclerosis. Arthritis Rheum. 34 (1991) 580-587
16. Hasegawa M., Fujimoto M., Kikuchi K., and Takehara K. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J. Rheumatol. 24 (1997) 328-332
17. Lammeli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277 (1970) 680-682
18. Deora A.A., Win T., Vanhaesebroeck B., and Lander H.M. A redox-triggered Ras-effector interaction. Recruitment of phosphatidylinositol 3′-kinase to Ras by redox stress. J. Biol. Chem. 273 (1998) 29923-29928
19. Wang X., McCullough K.D., Franke T.F., and Holbrook N.J. Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J. Biol. Chem. 276 (2000) 14624-14631
20. Beckman J.S., Chen J., Ischiropoulos H., and Crow C.P. Oxidative chemistry of peroxynitrite. Methods Enzymol. 233 (1994) 229-240
21. Li Z., Zhang G., Le Breton G.C., Gao X., Malik A.B., and Du X. Two waves of platelet secretion induced by thromboxane A2 receptor and a critical role for phosphoinositide 3-kinases. J. Biol. Chem. 278 (2003) 30725-30731
22. T.M. Chiang, A.E. Postlethwaite. Alteration in protein kinase B (Akt) activity in platelets from patients with systemic sclerosis, Biochem. Biophys. Acta. Mol. Basis Dis. (submitted for publication).
23. Rameh L.E., and Cantley L.C. The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274 (1999) 8347-8350
24. Coffer P.J., Jin J., and Woodgett J.B. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335 (1998) 1-13
25. Bhanot S., Salh B.S., Verma S., McNeill J.H., and Pelech S.L. In vivo regulation of protein-serine kinases by insulin in skeletal muscle of fructose-hypertensive rats. Am. J. Physiol. 277 (1999) E299-E307
26. Postlethwaite A.E., Shigemitsu H., and Kanangat S. Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis. Curr. Opin. Rheumatol. 16 (2004) 733-738
27. Hasegawa M., Fujimoto M., Kikuchi K., and Takehara F. Elevated serum level of IL-4, IL-10, and IL-13 in patients with systemic sclerosis. J. Rheumatol. 24 (1997) 328-332
28. Sato S., Hanakawa H., Nagaoka T., Hamaguchi Y., Nishijima C., Komatsu K., Hirata A., and Takahara K. Levels of IL-12, a cytokine of type I helper cells, are elevated in serum from patients with systemic sclerosis. J. Rheumatol. 27 (2000) 2838-2842
29. Riccieri V., Rinald T., Spadaro A., Scrivo R., Ceccarelli F., Frauco M.D., Taccari F., and Valesin C. IL-13 in systemic sclerosis: relationship to capillarosepy abnormalities. Clin. Rheumatol. 22 (2003) 102-106
30. Valentin G., Baroni A., Espositok K., Naclerio C., Boummino E., Farzati A., Cuomo G., and Frazatib B. Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation. J. Clin. Immunol. 21 (2001) 210-217
31. Warrington K.J., Nair U., Carbone L.D., Kang A.H., and Postlethwaite A.E. Characterization of the immune system and type I collagen in scleroderma. Arthritis Res. Ther. 8 (2006) 136-141